Your Location: Set Your Location
See services nearest you.
Essentia Health Menu
Home > About Us > Media Article Library > Essentia among first to use innovative technology for lung-cancer diagnosis
Published on September 30, 2021
A new innovation that holds promise to fight lung cancer is now in use at Essentia Health-St. Mary’s Medical Center. Used to view the inside of the lungs and obtain a tissue sample for biopsy, the goal of Auris Health’s Monarch™ Platform is to enable earlier and more-accurate diagnosis of small and hard-to-reach nodules in the periphery of the lung.
The technology integrates the latest advancements in robotics, software, data science and endoscopy — or the use of small cameras and tools to enter the body through its natural openings. Essentia Health is the first hospital in our region to introduce the platform, which recently was cleared by the U.S. Food and Drug Administration.
“With the development of lung-cancer screening, we have started to identify nodules sooner, leading to an earlier diagnosis and thus changing the natural history of the disease,” said Dr. Eric Swanson, a pulmonary/critical care physician at St. Mary’s Medical Center. “As a consequence, technology has also needed to advance in order to allow precise control to biopsy these smaller and more peripheral nodules. The Monarch robotic-assisted bronchoscopy platform is a new tool that allows us to maintain continued visualization during the procedure while improving our reach into the periphery of the lung, with improved precision when compared to prior bronchoscopic techniques.”
More than 90 percent of people diagnosed with lung cancer do not survive the disease, in part because it’s often found at an advanced stage. In fact, more people die every year from lung cancer than from prostate, breast and colon cancers combined. There are a variety of diagnostic options currently available for lung cancer, but all have limitations in accuracy, safety or invasiveness. These drawbacks can lead to false positives, false negatives or side effects such as pneumothorax (collapsed lung) and hemorrhage, which may increase health care costs and extend hospital stays.
The Monarch platform features a controller-like interface that physicians use to navigate the flexible robotic endoscope to the periphery of the lung with improved reach, vision and control. Combining traditional endoscopic views into the lung with computer-assisted navigation based on 3-D models of the patient’s own lung anatomy, the Monarch platform provides physicians with continuous bronchoscope vision throughout the entire procedure.
Why is this important for patients? Those who have small, peripheral nodules can be diagnosed earlier — and via a minimally invasive procedure — allowing for more successful outcomes in the treatment of their lung cancer. They don’t have to wait until their cancer is Stage 3 or Stage 4 to begin treating it.
To coordinate interviews, photos, and/or video, contact the media relations team.